Physician profile
Luis A Rodriguez
NPI 1053559922
$1,516.19
in general payments reported to CMS, 2019-2025
13 companies · $364 in 2025
The $364 reported for 2025 was more than what 79% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $274 · 2021: $125 · 2022: $70.92 · 2023: $31.71 · 2024: $102 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $375.21 | 2019-2021 | |
| Radius Health, INC. | $353.25 | 2019-2023 | Tymlos |
| Abbott Laboratories | $165.38 | 2025 | Diamondback Peripheral |
| Janssen Biotech, INC. | $162.87 | 2020-2025 | Tecvayli |
| Bioventus LLC | $106.88 | 2019-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $105.86 | 2019-2021 | |
| Southern Edge Orthopaedics, INC. | $64.50 | 2024 | |
| Amgen INC. | $45.84 | 2025 | Evenity |
| Depuy Synthes Sales INC. | $38.37 | 2025 | Monovisc |
| Ferring Pharmaceuticals INC. | $35.58 | 2019 | |
| Biotissue Holdings INC. | $25.13 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.19 | 2024 | Zilretta, Iovera |
| Sanofi-Aventis U.S. LLC | $17.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.